₹ 1.64
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Vivanza Biosciences Limited is a pharmaceutical firm specializing in the creation and commercialization of medicinal products. Among its offerings, the company prominently features Intravenous (IV) Fusion solutions. This enterprise was founded on March 3, 1982, and maintains its primary operational base in Ahmedabad, India.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITD.
Data is available to registered users only